 Alternatively, in radioimmunotherapy a radioactive dose localizes a target cell line, delivering lethal chemical doses.More recently antibodies have been used to bind to molecules involved in T-cell regulation to remove inhibitory pathways that block T-cell responses.This is known as immune checkpoint therapy.